Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
Abstract Prospective population-based studies investigating associations between reactive symptoms following SARS-CoV-2 vaccination and serologic responses to vaccination are lacking. We therefore conducted a study in 9003 adults from the UK general population receiving SARS-CoV-2 vaccines as part o...
Main Authors: | Hayley Holt, David A. Jolliffe, Mohammad Talaei, Sian Faustini, Giulia Vivaldi, Matthew Greenig, Alex G. Richter, Ronan A. Lyons, Christopher J. Griffiths, Frank Kee, Aziz Sheikh, Gwyneth A. Davies, Seif O. Shaheen, Adrian R. Martineau |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-023-00614-0 |
Similar Items
-
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
by: David A. Jolliffe, et al.
Published: (2022-09-01) -
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
by: Mohammad Talaei, et al.
Published: (2022-02-01) -
Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
by: Giulia Vivaldi, et al.
Published: (2022-11-01) -
Long-term symptom profiles after COVID-19 vs other acute respiratory infections: an analysis of data from the COVIDENCE UK studyResearch in context
by: Giulia Vivaldi, et al.
Published: (2023-11-01) -
Influence of individuals’ determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination
by: Emma S. Chambers, et al.
Published: (2024-05-01)